Abstract
The chemical stability of the new anticancer drug EO9 in aqueous solution has been investigated utilizing a stability-indicating reversed-phase high-performance liquid Chromatographie assay with ultraviolet detection and ultraviolet spectrophotornetry. The degradation kinetics of EO9 have been studied as a function of pH, buffer composition, ionic strength and temperature. A pH-rate profile, using rate constants extrapolated to zero buffer concentration, was constructed demonstrating that EO9 is most stable in the pH region 8–9. The degradation mechanism of EO9 in aqueous solution is discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
